{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:47:17Z","timestamp":1788353237757,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00417-020-04605-y","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T05:28:57Z","timestamp":1579238937000},"page":"767-772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["A proposal of an algorithm for the diagnosis and treatment of recurrence or treatment failure of retinopathy of prematurity after anti-VEGF therapy based on a large case series"],"prefix":"10.1007","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1265-3725","authenticated-orcid":false,"given":"Maria A.","family":"Mart\u00ednez-Castellanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-3376","authenticated-orcid":false,"given":"Ana","family":"Gonz\u00e1lez-H.Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5293-8103","authenticated-orcid":false,"given":"Juan C.","family":"Romo-Aguas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-4372","authenticated-orcid":false,"given":"Luis A.","family":"Gonzalez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"4605_CR1","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1172\/JCI42142.The","volume":"120","author":"P Sapieha","year":"2010","unstructured":"Sapieha P, Joyal J, Rivera JC et al (2010) Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest 120:3022\u20133032. https:\/\/doi.org\/10.1172\/JCI42142.The","journal-title":"J Clin Invest"},{"key":"4605_CR2","doi-asserted-by":"publisher","unstructured":"Cavallaro G, Filippi L, Bagnoli P et al (2014) The pathophysiology of retinopathy of prematurity : an update of previous and recent knowledge. Acta Opthalmologica:2\u201320. https:\/\/doi.org\/10.1111\/aos.12049","DOI":"10.1111\/aos.12049"},{"key":"4605_CR3","first-page":"1684","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:1684\u20131694","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4605_CR4","first-page":"1","volume":"123","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"2012","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group (2012) 15-year outcomes following threshold retinopathy of prematurity. Achives Ophthalmol 123:1\u20139","journal-title":"Achives Ophthalmol"},{"key":"4605_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajo.2004.12.106","volume":"140","author":"DK Coats","year":"2005","unstructured":"Coats DK, Miller AM, Hussein MAW et al (2005) Involution of retinopathy of prematurity after development of retinal detachment. Am J Ophthalmol 140:214\u2013222. https:\/\/doi.org\/10.1016\/j.ajo.2004.12.106","journal-title":"Am J Ophthalmol"},{"key":"4605_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3928\/15428877-20070501-09","volume":"38","author":"A Travassos","year":"2007","unstructured":"Travassos A, Teixeira S, Ferreira P et al (2007) Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retin 38:233\u2013237","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"4605_CR7","first-page":"6","volume":"81","author":"N O\u2019Keeffe","year":"2016","unstructured":"O\u2019Keeffe N, Murphy J, O\u2019Keefe M, Lanigan B (2016) Bevacizumab compared with diode laser in stage 3 posterior retinopathy of prematurity: a 5 year follow up. Ir Med J 81:6","journal-title":"Ir Med J"},{"key":"4605_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603\u2013615. https:\/\/doi.org\/10.1056\/NEJMoa1007374","journal-title":"N Engl J Med"},{"key":"4605_CR9","doi-asserted-by":"publisher","unstructured":"Yang X, Zhao Y, Wang Z, Lu L (2018) Effect of anti-VEGF treatment on retinopathy of prematurity in zone II stage 3 +. Int J Ophthalmol 11:641\u2013644. https:\/\/doi.org\/10.18240\/ijo.2018.04.17","DOI":"10.18240\/ijo.2018.04.17"},{"key":"4605_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/aos.13008","volume":"94","author":"R Karkhaneh","year":"2016","unstructured":"Karkhaneh R, Khodabande A, Riazi-eafahani M, Roohipoor R (2016) Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity. Acta Opthalmologica 94:417\u2013420. https:\/\/doi.org\/10.1111\/aos.13008","journal-title":"Acta Opthalmologica"},{"key":"4605_CR11","doi-asserted-by":"publisher","unstructured":"Pertl L, Steinwender G, Mayer C, Hausberger S (2015) A systematic review and meta-analysis on the safety of vascular endothelial growth factor (VEGF) inhibitors for the treatment of retinopathy of prematurity. PLoS One:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0129383","DOI":"10.1371\/journal.pone.0129383"},{"key":"4605_CR12","doi-asserted-by":"publisher","unstructured":"Sankar M, Sankar J, Mehta M et al (2016) Anti-vascular endothelial growth factor ( VEGF ) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009734.pub2","DOI":"10.1002\/14651858.CD009734.pub2"},{"key":"4605_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/IAE.0000000000000578","volume":"35","author":"RK Wong","year":"2015","unstructured":"Wong RK, Hubschman S, Tsui I (2015) Reactivation of retinopathy of prematurity after ranibizumab treatment. Retina 35:675\u2013680","journal-title":"Retina"},{"key":"4605_CR14","doi-asserted-by":"publisher","unstructured":"Martinez-Castellanos MA, Velez-Montoya R, Price K et al (2017) Vascular changes on fluorescein angiography of premature infants with low risk of retinopathy of prematurity after high oxygen exposure. Int J Retin Vitr 3. https:\/\/doi.org\/10.1186\/s40942-016-0055-6","DOI":"10.1186\/s40942-016-0055-6"},{"key":"4605_CR15","doi-asserted-by":"publisher","unstructured":"Arriola-lopez AE, Martinez-perez ME, Martinez-castellanos MA (2017) Retinal vascular changes in preterm infants: heart and lung diseases and plus disease. J AAPOS 21:488\u2013491.e1. https:\/\/doi.org\/10.1016\/j.jaapos.2017.08.004","DOI":"10.1016\/j.jaapos.2017.08.004"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04605-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-020-04605-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04605-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:08:59Z","timestamp":1610755739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-020-04605-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4605"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04605-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No informed consent was sought from patients in this study as only patient records that were accessible to medical professionals were obtained and collected for this study in a non-identifiable manner. In addition, no patient contact was required for this study, and outcomes for patients were not affected by the study due to its retrospective nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}